- Wink A de Boer, internista,
- Guido N J Tytgat, professorb
- aDepartment of Internal Medicine, Sint Anna Hospital, Postbus 10, 5340 BE Oss, Netherlands
- bDepartment of Gastroenterology and Hepatology, Academic Medical Centre, Amsterdam, Netherlands
- Correspondence to: W A de Boer
The bacterium Helicobacter pylori can infect the stomach during childhood and cause lifelong chronic gastritis, which can lead to peptic ulcer disease. Curing H pylori infection cures ulcer disease.1–5 And since reinfection in adults is extremely rare,6 adequate treatment permanently cures this former chronic recurrent, serious disease. If ulcers do not recur neither do ulcer perforation or bleeding; quality of life increases,7 sick leave decreases, and less money is spent on visiting the doctor and drugs.
Antibiotic resistance needs to be taken into account when designing treatment for H pylori infection.8 Over the past decade many different therapies were promoted and recommendations changed rapidly. Most doctors lost track, and a great variety of treatments is being used.9 In this article we will try to provide a basic framework on which treatment can be based.
Summary points
The therapeutic goal is to cure H pylori infection in all ulcer patients
Several equally effective regimens are available, but even the best fail in 5-20% of patients
Antibiotic resistance is usually induced after failure, and initial regimens should not compromise future therapeutic possibilities
Doctors should choose two complementary regimens, which if used consecutively come close to 100% cure
Treatment should start with a regimen based on clarithromycin with a back up regimen based on metronidazole unless resistance is above 15%, in which case the order should be reversed
Triple regimens which combine clarithromycin and metronidazole should not be used as there is no valid empirical back up regimen after failure
Methods
This article is based largely on our experience in treating H pyloriinfection. We base our recommendations on basic bacteriological principles and on a regularly updated in-house computer database that contains the results of all published therapeutic studies.
Who should be treated?
Treatment to eradicate H pylori in patients with a proved …
Sign in
Article access
Article access for 1 day
Purchase this article for £20 $30 €32*
The PDF version can be downloaded as your personal record







CiteULike
Connotea
Del.icio.us
Digg
Facebook
Mendeley
Reddit
Technorati
Twitter
Stumbleupon
Rapid responses
Latest Responses
Re: Ventilator associated pneumonia
Published 30 May 2012
Re: Restless legs syndrome
Published 30 May 2012
Author's reply
Published 30 May 2012
Re: Full access to trial data holds many benefits and a few pitfalls, conference hears
Published 30 May 2012
Restless Legs Syndrome: Fact or Fiction
Published 30 May 2012
Most responses
Venous thrombosis in users of non-oral hormonal contraception: follow-up study, Denmark 2001-10 (12 responses)
Published 10 May 2012 - 23:32
The psychiatric oligarchs who medicalise normality (9 responses)
Published 2 May 2012 - 15:42
Are doctors justified in taking industrial action in defence of their pensions? No (8 responses)
Published 8 May 2012 - 12:21
Are doctors justified in taking industrial action in defence of their pensions? Yes (8 responses)
Published 8 May 2012 - 12:21
The hardest thing: admitting error (7 responses)
Published 2 May 2012 - 12:27